NEW YORK CITY, NY / ACCESS Newswire / April 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

And GSK’s first-to-market Arexvy lived up to that expectation with $1.5 billion sales in its first year of commercialization. Related As RSV vaccine clash kicks off, GSK sues Pfizer for patent ...

GSK Plc and Pfizer Inc. settled a patent-infringement lawsuit over competing vaccines for RSV, ending the dispute in Delaware ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents, the ...

Officials in Delray Beach are inviting you to design the new logo for the city's historic Old School Square. Artists are urged to create a watercolor illustration that represents Old School Square, ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Fears of a plot by Russia to sabotage Britain's energy pipelines means families should pack a 72-hour 'survival kit', security advisers have warned. As the UK pursues Net Zero environmental ...

At close: April 1 at 4:00:02 PM EDT ...